End
1 :

Day 1:

Client is seen by provider for routine follow-up after being started on oxcarbazepine 150 mg PO twice a day, last week. Client reports no nausea, headache, dizziness, or ataxia. Provider increased oxcarbazepine to 300 mg PO twice a day. Client is to return for a follow-up in 2 weeks.

Day 14:

Client returns for follow-up after increasing oxcarbazepine dosage. Client reports starting to have mild headaches earlier this week. Also states, “Yesterday I was very nauseated and threw up before breakfast." When talking to client they have difficulty remembering the times they are taking their oxcarbazepine. Client reports using oral contraceptives as the only means of birth control.

Day 1:

Temperature 36.9°C (98.4°F)

Heart rate 78/min

Blood pressure 118/76 mm Hg

Respiratory rate 18/min

Day 14:

Temperature 36.3°C (97.4°F)

Heart rate 86/min

Blood pressure 110/66 mm Hg

Respiratory rate 16/min

Day 1:

Hct (37% to 47%)

Hgb 14g/dL (12 to 16g/dL)

Sodium 140 mEq/L (136 to 145 mEq/L)

Day 14:

Hct (37% to 47%)

Hgb 13g/dL (12 to 16g/dL)

Sodium 124 mEq/L (136 to 145 mEq/L)


Click to highlight the findings that require immediate follow-up. To deselect a finding click on the finding again.


Nurses' Notes Day 1: Client is seen by provider for routine follow-up after being started on oxcarbazepine 150mg PO twice a day, last week. Client reports no nausea, headache. dizziness. or ataxia. Provider increased oxcarbazepine to 300 mg PO twice a day. Client is to return for a follow-up in 2 weeks. Day 14: Client returns for follow-up after increasing oxcarbazepine dosage. Client reports starting to have mild headaches earlier this week. Also states. "Yesterday I was very nauseated and threw up before breakfast.” When talking to client they have difficulty remembering the times they are taking their oxcarbazepine. Client reports using oral contraceptives as the only means of birth control. Laboratory-Results Day 1: Hct (37% to 47%) Hgb 14g/dL (12 to 16g/dL) Sodium 140 mEq/L (136 to 145 mEq/L) Day 14: Hct (37% to 47%) Hgb 13g/dL (12 to 16g/dL) Sodium 124 mEq/L (136 to 145 mEq/L)


Hint : ⚠️ Watch sodium + birth control risk.

Correct Highlights :
  • Client reports using oral contraceptives as the only means of birth control.
  • Sodium 124 mEq/L (136 to 145 mEq/L)

Rationale :

Sodium 124 mEq/L

  1. Normal range is 136–145 mEq/L; this result shows severe hyponatremia.
  2. Oxcarbazepine can cause SIADH (syndrome of inappropriate antidiuretic hormone secretion), leading to water retention and dilutional hyponatremia.
  3. This explains the client’s headaches, nausea, and vomiting, which are early signs of hyponatremia.
  4. If untreated, this can progress to confusion, seizures, coma, and death.
  5. Requires urgent evaluation, medication adjustment, and possible hospitalization for electrolyte correction.

Client reports using oral contraceptives as the only means of birth control

  1. Oxcarbazepine reduces the effectiveness of oral contraceptives by inducing hepatic enzymes, which accelerates estrogen metabolism.
  2. This places the client at high risk for unintended pregnancy.
  3. Requires immediate counseling on using an additional or alternative form of contraception.

Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

QLexNursing Calculator Click & Drag ×
AC
(
)
CE
π
e
φ
τ
Inv
sin-1
cos-1
tan-1
log
ln
!
deg
√
x²
x³
^
7
8
9
÷
4
5
6
×
1
2
3
-
0
.
exp
+
Rnd
Ans
=